Skip to main content

Laboratories in research centres to do rapid COVID-19 detection tests

Images

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Several media have reported on the platform set up by IRB Barcelona, the Center for Genomic Regulation (CRG) and the Institute for Bioengineering of Catalonia (IBEC) for mass testing for  COVID-19, which seeks to contribute to halting the spread of the virus. In this regard, the labs at IRB Barcelona will conduct sample analysis to detect infected individuals during lockdown and also when confinement measures are progressively relaxed. 

The director of IRB Barcelona, Francesc Posas, has expressed his satisfaction at being able to adapt the activity of his centre to support society at a time when mass detection is crucial for controlling the spread of the virus. 

Link to: La Vanguardia

Link to: ABC

Link to: Ara

Link to: Ara

Link to: La Razón

Link to: Betevé

Link to: Europa Press

Link to: El Punt Avui

Link to: 20 minutos

Link to: Naciodigital

Link to: elmon.cat

IRB Barcelona is working on tackling the coronavirus pandemic: find out about our projects.

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).